Malignant Central Nervous System Neoplasm

Malignant Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,864 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 822
Recruiting: 449
Ph III recruiting: 27
Growth YoY: +21.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%
Trials / 1,000 deaths: 45.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (419)

clinicaltrialsPublishedShowing 301–310 of 310 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00683761	A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma	unknown	Phase 1 / Phase 2	64	TransMolecularINDUSTRY	1	Jul 17, 2009	clinicaltrials
NCT00114309	131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma	unknown	Phase 2	66	TransMolecularINDUSTRY	1	Apr 3, 2009	clinicaltrials
NCT00180791